Since it is significantly expressed in AML cells but not in healthy HSC or non-hematological cells, C-type lectin-like molecule 1 (CLL1) represents a promising target for CAR-T cells (Fig. 2). The gene discussed is CLEC12A; the disease is acute myeloid leukemia.